Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20

Rhea-AI Summary

Surmodics, Inc. (Nasdaq: SRDX) has announced its participation in the 22nd Annual Needham Virtual Healthcare Conference, taking place from April 17-20, 2023. Management will present on April 20 at 10:15 a.m. ET. Investors can access the live webcast of the presentation via the company’s website under the 'Events & Presentations' section. A replay will be available for 90 days post-event.

Surmodics specializes in performance coating technologies for medical devices and in vitro diagnostic tests, with a focus on developing solutions for unmet clinical needs. Headquartered in Eden Prairie, Minnesota, the company aims to enhance disease detection and treatment through innovative technologies.

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the 22nd Annual Needham Virtual Healthcare Conference, which is being held from April 17-20, 2023. Management will present on Thursday, April 20, at 10:15 a.m. ET (9:15 a.m. CT).

A live webcast of the presentation can be accessed by going to “Events & Presentations” under the “Investors” section of the company’s website at https://surmodics.gcs-web.com/events-and-presentations, and clicking on the webcast icon under “Upcoming Events.” A replay of the webcast will be archived on the website for the following 90 days.

About Surmodics, Inc.

Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities. The Company’s mission is to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230411005019/en/

Surmodics Investor Inquiries:

Jack Powell, Investor Relations

ir@surmodics.com

Source: Surmodics, Inc.

FAQ

When will Surmodics present at the Needham Virtual Healthcare Conference?

Surmodics will present on April 20, 2023, at 10:15 a.m. ET.

How can I access the webcast for Surmodics' presentation?

The webcast can be accessed on Surmodics' website in the 'Events & Presentations' section.

What is the duration of the replay for Surmodics' conference presentation?

The replay of the presentation will be available for 90 days after the event.

What does Surmodics, Inc. specialize in?

Surmodics specializes in performance coating technologies for medical devices and in vitro diagnostic tests.

Where is Surmodics, Inc. headquartered?

Surmodics is headquartered in Eden Prairie, Minnesota.